David Pernock
2018 - Eagle Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $289,467 |
|---|---|
| Option Awards | $1,337,527 |
| Salary | $540,653 |
| Stock Awards | $1,493,300 |
| Other | $14,497 |
| Total | $3,675,444 |
Pernock received $1.5M in stock awards, accounting for 41% of the total pay in 2018.
Pernock also received $289.5K in non-equity incentive plan, $1.3M in option awards, $540.7K in salary and $14.5K in other compensation.
Rankings
In 2018, David Pernock's compensation ranked 3,066th out of 14,244 executives tracked by ExecPay. In other words, Pernock earned more than 78.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,066 out of 14,244 | 79th |
Division Manufacturing | 1,134 out of 5,759 | 80th |
Major group Chemicals And Allied Products | 391 out of 2,122 | 82nd |
Industry group Drugs | 321 out of 1,811 | 82nd |
Industry Pharmaceutical Preparations | 245 out of 1,385 | 82nd |
Pay ratio
| David Pernock's Pay | $3,675,444 |
|---|---|
| Median Employee's Pay | $236,618 |
| Pay Ratio | 16to 1 |
In 2018, the annual total compensation of David Pernock was $3,675,444.
The annual total compensation of the median employee at Eagle Pharmaceuticals was $236,618.
The ratio of David Pernock's pay to the pay of median employee was therefore 16 to one.
Pernock's colleagues
We found four more compensation records of executives who worked with David Pernock at Eagle Pharmaceuticals in 2018.
News
June 15, 2022
April 30, 2021
April 29, 2020
April 30, 2019